Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Influenza

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 69 articles:
HTML format



Single Articles


    November 2021
  1. LIU Y, Budylowski P, Dong S, Li Z, et al
    SARS-CoV-2-Reactive Mucosal B Cells in the Upper Respiratory Tract of Uninfected Individuals.
    J Immunol. 2021;207:2581-2588.
    PubMed     Abstract available


  2. HUSSAIN SA, Rohlfing M, Resiliac J, Santoro J, et al
    Atopic Neutrophils Prevent Postviral Airway Disease.
    J Immunol. 2021;207:2589-2597.
    PubMed     Abstract available


  3. GAJANAYAKA N, Dong SXM, Ali H, Iqbal S, et al
    TLR-4 Agonist Induces IFN-gamma Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.
    J Immunol. 2021;207:2310-2324.
    PubMed     Abstract available


    October 2021
  4. WANG Y, Karki R, Zheng M, Kancharana B, et al
    Cutting Edge: Caspase-8 Is a Linchpin in Caspase-3 and Gasdermin D Activation to Control Cell Death, Cytokine Release, and Host Defense during Influenza A Virus Infection.
    J Immunol. 2021 Oct 18. pii: jimmunol.2100757. doi: 10.4049/jimmunol.2100757.
    PubMed     Abstract available


  5. BANSAL S, Perincheri S, Fleming T, Poulson C, et al
    Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines.
    J Immunol. 2021 Oct 15. pii: jimmunol.2100637. doi: 10.4049/jimmunol.2100637.
    PubMed     Abstract available


  6. PAIDI RK, Jana M, Mishra RK, Dutta D, et al
    Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
    J Immunol. 2021 Oct 13. pii: jimmunol.2100144. doi: 10.4049/jimmunol.2100144.
    PubMed     Abstract available


  7. YANG Q, Wen Y, Qi F, Gao X, et al
    Suppressive Monocytes Impair MAIT Cells Response via IL-10 in Patients with Severe COVID-19.
    J Immunol. 2021;207:1848-1856.
    PubMed     Abstract available


  8. SCOTT J, Ruchaud-Sparagano MH, Musgrave K, Roy AI, et al
    Phosphoinositide 3-Kinase delta Inhibition Improves Neutrophil Bacterial Killing in Critically Ill Patients at High Risk of Infection.
    J Immunol. 2021;207:1776-1784.
    PubMed     Abstract available


    September 2021
  9. ALVES I, Vicente MM, Gaifem J, Fernandes A, et al
    SARS-CoV-2 Infection Drives a Glycan Switch of Peripheral T Cells at Diagnosis.
    J Immunol. 2021;207:1591-1598.
    PubMed     Abstract available



  10. Top Reads.
    J Immunol. 2021;207:1495.
    PubMed    


  11. MA T, Ryu H, McGregor M, Babcock B, et al
    Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8(+) T Cells during Convalescence.
    J Immunol. 2021;207:1344-1356.
    PubMed     Abstract available


    August 2021
  12. SHAHBAZ S, Xu L, Sligl W, Osman M, et al
    The Quality of SARS-CoV-2-Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated.
    J Immunol. 2021;207:1099-1111.
    PubMed     Abstract available


  13. OCHSNER SP, Li W, Rajendrakumar AM, Palaniyandi S, et al
    FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100297. doi: 10.4049/jimmunol.2100297.
    PubMed     Abstract available


  14. VERMA AK, Bauer C, Palani S, Metzger DW, et al
    IFN-gamma Drives TNF-alpha Hyperproduction and Lethal Lung Inflammation during Antibiotic Treatment of Postinfluenza Staphylococcus aureus Pneumonia.
    J Immunol. 2021 Aug 11. pii: jimmunol.2100328. doi: 10.4049/jimmunol.2100328.
    PubMed     Abstract available


  15. REYNOLDS D, Vazquez Guillamet C, Day A, Borcherding N, et al
    Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.
    J Immunol. 2021 Aug 4. pii: jimmunol.2100294. doi: 10.4049/jimmunol.2100294.
    PubMed     Abstract available


  16. BAYARRI-OLMOS R, Idorn M, Rosbjerg A, Perez-Alos L, et al
    SARS-CoV-2 Neutralizing Antibody Responses towards Full-Length Spike Protein and the Receptor-Binding Domain.
    J Immunol. 2021;207:878-887.
    PubMed     Abstract available


    June 2021
  17. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Correction: Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2021 Jun 18. pii: jimmunol.2100261. doi: 10.4049/jimmunol.2100261.
    PubMed    


  18. SANDOR AM, Sturdivant MS, Ting JPY
    Influenza Virus and SARS-CoV-2 Vaccines.
    J Immunol. 2021;206:2509-2520.
    PubMed     Abstract available


  19. JAHRSDORFER B, Gross R, Seidel A, Wettstein L, et al
    Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
    J Immunol. 2021;206:2614-2622.
    PubMed     Abstract available


  20. MANTUS G, Nyhoff LE, Kauffman RC, Edara VV, et al
    Evaluation of Cellular and Serological Responses to Acute SARS-CoV-2 Infection Demonstrates the Functional Importance of the Receptor-Binding Domain.
    J Immunol. 2021;206:2605-2613.
    PubMed     Abstract available


    May 2021
  21. OCCHIGROSSI L, Rossin F, D'Eletto M, Farrace MG, et al
    Transglutaminase 2 Regulates Innate Immunity by Modulating the STING/TBK1/IRF3 Axis.
    J Immunol. 2021;206:2420-2429.
    PubMed     Abstract available


  22. FUJIGAKI H, Inaba M, Osawa M, Moriyama S, et al
    Comparative Analysis of Antigen-Specific Anti-SARS-CoV-2 Antibody Isotypes in COVID-19 Patients.
    J Immunol. 2021;206:2393-2401.
    PubMed     Abstract available


  23. YAN Q, Li P, Ye X, Huang X, et al
    Longitudinal Peripheral Blood Transcriptional Analysis Reveals Molecular Signatures of Disease Progression in COVID-19 Patients.
    J Immunol. 2021;206:2146-2159.
    PubMed     Abstract available


    April 2021
  24. CROOKE PS 3RD, Tossberg JT, Porter KP, Aune TM, et al
    Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.
    J Immunol. 2021;206:1691-1696.
    PubMed     Abstract available


  25. HUANG W, Li M, Luo G, Wu X, et al
    The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression.
    J Immunol. 2021;206:1597-1608.
    PubMed     Abstract available


  26. RUPP J, Dreo B, Gutl K, Fessler J, et al
    T Cell Phenotyping in Individuals Hospitalized with COVID-19.
    J Immunol. 2021;206:1478-1482.
    PubMed     Abstract available


  27. FRANZETTI M, Forastieri A, Borsa N, Pandolfo A, et al
    IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study.
    J Immunol. 2021;206:1569-1575.
    PubMed     Abstract available


  28. PRICE MJ, Scharer CD, Kania AK, Randall TD, et al
    Conserved Epigenetic Programming and Enhanced Heme Metabolism Drive Memory B Cell Reactivation.
    J Immunol. 2021;206:1493-1504.
    PubMed     Abstract available


    March 2021
  29. MALINCZAK CA, Parolia A, Fonseca W, Morris S, et al
    TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    J Immunol. 2021;206:1315-1328.
    PubMed     Abstract available


    February 2021
  30. TIAN J, Zhang M, Jin M, Zhang F, et al
    Repurposed Tocilizumab in Patients with Severe COVID-19.
    J Immunol. 2021;206:599-606.
    PubMed     Abstract available


  31. ZELBA H, Worbs D, Harter J, Pieper N, et al
    A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4(+) and CD8(+) T Cells in COVID-19 Patients.
    J Immunol. 2021;206:580-587.
    PubMed     Abstract available


    January 2021
  32. SCHWARZ B, Sharma L, Roberts L, Peng X, et al
    Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators.
    J Immunol. 2021;206:329-334.
    PubMed     Abstract available


  33. JOAG V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, et al
    Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses.
    J Immunol. 2021 Jan 13. pii: jimmunol.2001400. doi: 10.4049/jimmunol.2001400.
    PubMed     Abstract available


  34. HANSEN CB, Jarlhelt I, Perez-Alos L, Hummelshoj Landsy L, et al
    SARS-CoV-2 Antibody Responses Are Correlated to Disease Severity in COVID-19 Convalescent Individuals.
    J Immunol. 2021;206:109-117.
    PubMed     Abstract available


    December 2020
  35. MARTINI V, Paudyal B, Chrun T, McNee A, et al
    Simultaneous Aerosol and Intramuscular Immunization with Influenza Vaccine Induces Powerful Protective Local T Cell and Systemic Antibody Immune Responses in Pigs.
    J Immunol. 2020 Dec 16. pii: jimmunol.2001086. doi: 10.4049/jimmunol.2001086.
    PubMed     Abstract available


  36. VOGELZANG EH, Loeff FC, Derksen NIL, Kruithof S, et al
    Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
    J Immunol. 2020;205:3491-3499.
    PubMed     Abstract available


  37. MARTINEZ-FLETA P, Alfranca A, Gonzalez-Alvaro I, Casasnovas JM, et al
    SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19-Seropositive Individuals.
    J Immunol. 2020;205:3130-3140.
    PubMed     Abstract available


  38. KELLAR GG, Reeves SR, Barrow KA, Debley JS, et al
    Juvenile, but Not Adult, Mice Display Increased Myeloid Recruitment and Extracellular Matrix Remodeling during Respiratory Syncytial Virus Infection.
    J Immunol. 2020;205:3050-3057.
    PubMed     Abstract available


    November 2020
  39. LAW JC, Koh WH, Budylowski P, Lin J, et al
    Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.
    J Immunol. 2020 Nov 18. pii: jimmunol.2001067. doi: 10.4049/jimmunol.2001067.
    PubMed     Abstract available


  40. KALKAN YAZICI M, Koc MM, Cetin NS, Karaaslan E, et al
    Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.
    J Immunol. 2020;205:2719-2725.
    PubMed     Abstract available


  41. NOWILL AE, de Campos-Lima PO
    Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
    J Immunol. 2020;205:2566-2575.
    PubMed     Abstract available


  42. BAUMGARTH N, Nikolich-Zugich J, Lee FE, Bhattacharya D, et al
    Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.
    J Immunol. 2020;205:2342-2350.
    PubMed     Abstract available


  43. VARNAITE R, Garcia M, Glans H, Maleki KT, et al
    Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    J Immunol. 2020;205:2437-2446.
    PubMed     Abstract available


    October 2020
  44. ELAHI S
    Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.
    J Immunol. 2020;205:1990-1997.
    PubMed     Abstract available


    September 2020
  45. SOKULSKY LA, Garcia-Netto K, Nguyen TH, Girkin JLN, et al
    A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation.
    J Immunol. 2020 Sep 18. pii: jimmunol.1901350. doi: 10.4049/jimmunol.1901350.
    PubMed     Abstract available


  46. WONG LR, Ye ZW, Lui PY, Zheng X, et al
    Middle East Respiratory Syndrome Coronavirus ORF8b Accessory Protein Suppresses Type I IFN Expression by Impeding HSP70-Dependent Activation of IRF3 Kinase IKKepsilon.
    J Immunol. 2020;205:1564-1579.
    PubMed     Abstract available


  47. LO MW, Kemper C, Woodruff TM
    COVID-19: Complement, Coagulation, and Collateral Damage.
    J Immunol. 2020;205:1488-1495.
    PubMed     Abstract available


  48. XIA J, Kuang Y, Liang J, Jones M, et al
    Influenza Vaccine-Induced CD4 Effectors Require Antigen Recognition at an Effector Checkpoint to Generate CD4 Lung Memory and Antibody Production.
    J Immunol. 2020 Sep 14. pii: jimmunol.2000597. doi: 10.4049/jimmunol.2000597.
    PubMed     Abstract available


  49. FRANCO R, Rivas-Santisteban R, Serrano-Marin J, Rodriguez-Perez AI, et al
    SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
    J Immunol. 2020;205:1198-1206.
    PubMed     Abstract available


    August 2020
  50. ASSMUS LM, Guan J, Wu T, Farenc C, et al
    Overlapping Peptides Elicit Distinct CD8(+) T Cell Responses following Influenza A Virus Infection.
    J Immunol. 2020 Aug 31. pii: jimmunol.2000689. doi: 10.4049/jimmunol.2000689.
    PubMed     Abstract available


  51. ORLOV M, Wander PL, Morrell ED, Mikacenic C, et al
    A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections.
    J Immunol. 2020;205:892-898.
    PubMed     Abstract available


  52. ALSOUSSI WB, Turner JS, Case JB, Zhao H, et al
    A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
    J Immunol. 2020;205:915-922.
    PubMed     Abstract available


  53. VERMA AK, Bansal S, Bauer C, Muralidharan A, et al
    Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive Streptococcus pneumoniae to Cause Deadly Pneumonia.
    J Immunol. 2020 Aug 12. pii: jimmunol.2000094. doi: 10.4049/jimmunol.2000094.
    PubMed     Abstract available


  54. ST JOHN AL, Rathore APS
    Early Insights into Immune Responses during COVID-19.
    J Immunol. 2020;205:555-564.
    PubMed     Abstract available


    July 2020
  55. YAP JKY, Moriyama M, Iwasaki A
    Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19.
    J Immunol. 2020;205:307-312.
    PubMed     Abstract available


  56. CHEN J, Kelley WJ, Goldstein DR
    Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.
    J Immunol. 2020;205:313-320.
    PubMed     Abstract available


  57. MANJILI RH, Zarei M, Habibi M, Manjili MH, et al
    COVID-19 as an Acute Inflammatory Disease.
    J Immunol. 2020;205:12-19.
    PubMed     Abstract available


    June 2020
  58. MCNEE A, Smith TRF, Holzer B, Clark B, et al
    Establishment of a Pig Influenza Challenge Model for Evaluation of Monoclonal Antibody Delivery Platforms.
    J Immunol. 2020 Jun 26. pii: jimmunol.2000429. doi: 10.4049/jimmunol.2000429.
    PubMed     Abstract available


  59. CASALINO-MATSUDA SM, Chen F, Gonzalez-Gonzalez FJ, Nair A, et al
    Hypercapnia Suppresses Macrophage Antiviral Activity and Increases Mortality of Influenza A Infection via Akt1.
    J Immunol. 2020 Jun 15. pii: jimmunol.2000085. doi: 10.4049/jimmunol.2000085.
    PubMed     Abstract available


  60. TOBIN JM, Nickolich KL, Ramanan K, Pilewski MJ, et al
    Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis.
    J Immunol. 2020 Jun 10. pii: jimmunol.2000067. doi: 10.4049/jimmunol.2000067.
    PubMed     Abstract available


    May 2020
  61. ALAM F, Singh A, Flores-Malavet V, Sell S, et al
    CD25-Targeted IL-2 Signals Promote Improved Outcomes of Influenza Infection and Boost Memory CD4 T Cell Formation.
    J Immunol. 2020 May 6. pii: jimmunol.2000205. doi: 10.4049/jimmunol.2000205.
    PubMed     Abstract available


    February 2020
  62. AVEY S, Mohanty S, Chawla DG, Meng H, et al
    Seasonal Variability and Shared Molecular Signatures of Inactivated Influenza Vaccination in Young and Older Adults.
    J Immunol. 2020 Feb 14. pii: jimmunol.1900922. doi: 10.4049/jimmunol.1900922.
    PubMed     Abstract available


    January 2020
  63. BLUNDELL PA, Lu D, Dell A, Haslam S, et al
    Choice of Host Cell Line Is Essential for the Functional Glycosylation of the Fc Region of Human IgG1 Inhibitors of Influenza B Viruses.
    J Immunol. 2020 Jan 6. pii: jimmunol.1901145. doi: 10.4049/jimmunol.1901145.
    PubMed     Abstract available


  64. MALINCZAK CA, Rasky AJ, Fonseca W, Schaller MA, et al
    Upregulation of H3K27 Demethylase KDM6 During Respiratory Syncytial Virus Infection Enhances Proinflammatory Responses and Immunopathology.
    J Immunol. 2020;204:159-168.
    PubMed     Abstract available


    December 2019
  65. SAUTTO GA, Kirchenbaum GA, Abreu RB, Ecker JW, et al
    A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin.
    J Immunol. 2019 Dec 6. pii: jimmunol.1900379. doi: 10.4049/jimmunol.1900379.
    PubMed     Abstract available


    November 2019
  66. ZACHARIAS ZR, Legge KL
    Chronic Ethanol Consumption Reduces Existing CD8 T Cell Memory and Is Associated with Lesions in Protection against Secondary Influenza A Virus Infections.
    J Immunol. 2019 Nov 11. pii: jimmunol.1900770. doi: 10.4049/jimmunol.1900770.
    PubMed     Abstract available


    April 2019
  67. SCHMIDT ME, Oomens AGP, Varga SM
    Vaccination with a Single-Cycle Respiratory Syncytial Virus Is Immunogenic and Protective in Mice.
    J Immunol. 2019 Apr 19. pii: jimmunol.1900050. doi: 10.4049/jimmunol.1900050.
    PubMed     Abstract available


    February 2019
  68. PERCOPO CM, Ma M, Brenner TA, Krumholz JO, et al
    Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection.
    J Immunol. 2019;202:871-882.
    PubMed     Abstract available


    January 2019
  69. JAMIESON KC, Traves SL, Kooi C, Wiehler S, et al
    Rhinovirus and Bacteria Synergistically Induce IL-17C Release from Human Airway Epithelial Cells To Promote Neutrophil Recruitment.
    J Immunol. 2019;202:160-170.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: